Petros Pharmaceuticals Inc (NASDAQ:PTPI) currently has a daily average trading volume of 7.65M but it saw 8597904 shares traded in last market. With a market cap of 2.75M USD, the company’s current market price of $0.09 came falling about -10.34 while comparing to the previous closing price of $0.10. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.67 and as low as $0.07. In the recent trading on the day, stock has struck highest price mark of $0.0856 while lowest mark touched by it was $0.0994.
Taking a look at 20-day trading activity of Petros Pharmaceuticals Inc (PTPI) gives us an average price of $0.1314, while its current price level is -94.50% below from 52-week high level whereas it is 25.72% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2462 while that of 200 days or SMA-200 reads an average of $0.3425. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.53% during that period while stretching the period over a month that increases to 24.85%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 32.53 which implies that the stock is in neutral territory.
Over the week, PTPI’s stock price is moving 2.11% up while it is -66.09% when we observe its performance for the past one month. Year-to-date it is -76.67% down and over the past year, the stock is showing a downside performance of -94.36%.
The company is expected to be releasing its next quarterly report on 2024-Nov-12, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Petros Pharmaceuticals Inc’s total number of outstanding shares is 25.27M with 6.81% of that held by the insiders while 10.28% of its common stock has been owned by the institutions. Stock’s beta reads 1.85. Stock has a price to book (P/B) ratio of 0.30.
